FDA Grand Rounds: Postmarket Regulation of Cosmetic Products Set for Feb. 5 Online

FDA Grand Rounds: Postmarket Regulation of Cosmetic Products: The Who, What, When, Why and How is slated for Feb. 5 from 12-1pm ET via webcast on Microsoft Teams. CME credit will be offered through the Johns Hopkins University School of Medicine.

This lecture will provide a comprehensive overview of the FDA’s regulatory authorities over cosmetic products. Participants will also learn about the various tools available for industry to register their facilities and list their cosmetic products as required by MoCRA, and how industry and consumers can report adverse events from use of cosmetic products to the FDA.

Speakers include: Elizabeth Petro, PhD, supervisory chemist & branch chief; Megumi Yamamoto, MS, chemist, project manager for cosmetic registration and listing; and Jannavi Srinivisan, PhD, director, division of cosmetics, office of cosmetics and colors, office of the chief scientist, US Food and Drug Administration.

Learning Objectives

Explain the FDA’s regulatory requirements for submitting adverse event reports for cosmetic products. 

Describe the available methods of reporting adverse event associated with the use of cosmetic products. 

Understand the key regulatory requirements for the registration and listing of cosmetic product facilities and products under the Modernization of Cosmetics Regulation Act (MoCRA), including who must comply, what information is required and how to navigate the FDA’s registration and listing process.

Continuing Medical Education (CME) Credit

As CME credit is being offered through the Johns Hopkins University School of Medicine, those wishing to obtain CME credit must create a user profile on the Hopkins Cloud CME platform.

Accreditation Statement

The Johns Hopkins University School of Medicine is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

About the Speakers

Dr. Elizabeth Petro graduated with a bachelor’s degree in biological chemistry from the University of Chicago in 2006 and a doctorate in biological chemistry from the Johns Hopkins University School of Medicine in 2013.  Dr. Petro joined the FDA in 2014 reviewing food contact substance notifications in what was at that time the Office of Food Additive Safety in the FDA’s Center for Food Safety and Applied Nutrition (CFSAN).  Since January 2022, Dr. Petro has led the Cosmetics Regulatory Activities Branch, coordinating the FDA’s regulatory and compliance activities for cosmetic products.

Megumi Yamamoto is the project manager for Cosmetic Registration and Listing at the FDA, where she leads efforts related to the registration and listing of cosmetic product facilities and products under the Modernization of Cosmetics Regulation Act (MoCRA). Before joining the FDA in 2019, Yamamoto spent over 14 years in the cosmetics industry, specializing in formulation and product development for global brands such as Coty, Avon and Estée Lauder. She holds a master’s degree in cosmetic science from Fairleigh Dickinson University and a bachelor’s degree in chemistry from the University of Connecticut.

Dr. Jannavi Srinivasan is the director of the Division of Cosmetics, Office of Cosmetics and Colors (OCAC), Office of the Chief Scientist, at the FDA. She provides scientific, compliance and policy leadership on matters related to the chemical, toxicological, and microbiological safety of cosmetics raw materials, ingredients, and products. Prior to her current role, Dr. Srinivasan served as a chemist and team lead for 15 years in what is currently the Human Foods Program at the FDA; she performed chemistry and dietary exposure assessments for premarket reviews of food and color additives, and Generally Recognized as Safe (GRAS) substances, and served in an international capacity as an invited independent expert and member of the Joint FAO/WHO Expert Committee on Food Additives (JECFA) (2011-present) – the scientific advisory body to Codex Committee of Food Additives (CCFA), and as a technical expert on the FDA delegation to OECD’s Working Party on Novel Foods and Feeds (2009-2022).